Literature DB >> 32762139

Urinary vanin-1 and chronic kidney disease in hypertensive patients.

Yuanyuan Zhang1, Xianhui Qin1.   

Abstract

Entities:  

Keywords:  biomarkers; chronic kidney disease; hypertension; vanin-1

Mesh：

Year:  2020        PMID： 32762139      PMCID： PMC8029805          DOI： 10.1111/jch.13967

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  31 in total

1.  Relationship of visceral adiposity index with new-onset proteinuria in hypertensive patients.

Authors:  Mengyi Liu; Chun Zhou; Zhuxian Zhang; Panpan He; Yuanyuan Zhang; Di Xie; Jing Nie; Min Liang; Yun Song; Chengzhang Liu; Lishun Liu; Yong Huo; Binyan Wang; Xiaobin Wang; Xiping Xu; Xianhui Qin
Journal:  Clin Nutr       Date:  2020-06-02       Impact factor: 7.324

2.  BMI is associated with the development of chronic kidney diseases in hypertensive patients with normal renal function.

Authors:  Liling Xie; Binyan Wang; Chongfei Jiang; Xianglin Zhang; Yun Song; Youbao Li; Jiancheng Wang; Yaren Yu; Min Liang; Guobao Wang; Yan Zhang; Jianping Li; Yong Huo; Xiping Xu; Jing Nie; Xianhui Qin
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

3.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

Review 4.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

Review 5.  Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.

Authors:  Esmeralda Castillo-Rodriguez; Raul Fernandez-Prado; Catalina Martin-Cleary; Maria Soledad Pizarro-Sánchez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Beatriz Fernandez-Fernandez; Alberto Ortiz
Journal:  Nephron       Date:  2016-10-22       Impact factor: 2.847

6.  U-shaped association between serum albumin and development of chronic kidney disease in general hypertensive patients.

Authors:  Chongfei Jiang; Binyan Wang; Youbao Li; Liling Xie; Xianglin Zhang; Jiancheng Wang; Yaren Yu; Yun Song; Min Liang; Guobao Wang; Jianping Li; Yan Zhang; Lishun Liu; Chengzhang Liu; Genfu Tang; Yong Huo; Xiping Xu; Xianhui Qin
Journal:  Clin Nutr       Date:  2019-02-14       Impact factor: 7.324

7.  Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury.

Authors:  Keiko Hosohata; Hitoshi Ando; Yoko Fujiwara; Akio Fujimura
Journal:  Toxicology       Date:  2011-09-03       Impact factor: 4.221

8.  Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Nrupen A Bhavsar; Anna Köttgen; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2012-04-28       Impact factor: 8.860

9.  A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study.

Authors:  Satoshi Washino; Keiko Hosohata; Masashi Oshima; Tomohisa Okochi; Tsuzumi Konishi; Yuhki Nakamura; Kimitoshi Saito; Tomoaki Miyagawa
Journal:  Int J Mol Sci       Date:  2019-02-19       Impact factor: 5.923

Review 10.  Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.

Authors:  Sebastian J Klein; Anna K Brandtner; Georg F Lehner; Hanno Ulmer; Sean M Bagshaw; Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2018-03-14       Impact factor: 17.440
View more
  1 in total

1.  Urinary vanin-1 and chronic kidney disease in hypertensive patients.

Authors:  Yuanyuan Zhang; Xianhui Qin
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.